Form 4 for BHVN Biohaven Ltd.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-02 · accession 0001935979-24-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-10-03 | 2024-10-02 | BHVN | Coric Vlad | CEO, Dir | P - Purchase | $47.50 | +21.1K | 861.9K | +3% | +$1000.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-10-02 | P | A | 21,052 | $47.50 | 861,942 | I By: The Vlad Coric Family Trust | — | — | (F1) Represents common shares acquired in an underwritten public offering. (F2) These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |